Insmed Incorporated (INSM)
Data as of September 10, 2026 · Medical - Pharmaceuticals
Stockbruh grade: Challenging 1/5 metrics rated Sunny
What does Insmed Incorporated do?
Insmed Incorporated, a kickass biopharmaceutical company, develops life-changing therapies for peeps with rare diseases. With headquarters in Bridgewater, New Jersey, they've got ARIKAYCE for treating lung disease and Brensocatib for bronchiectasis, plus more cool stuff coming. Let's just say they're all about making your health happier! 🌟💊🔬.
Key Numbers
| Metric | Rating | What it means |
|---|
| Returns (5Y) | ☀️ Strong | 5-year price performance |
| Profitability | ⛈️ Weak | Net margin & return on equity |
| Growth | ⛈️ Weak | Revenue & earnings trend |
| Earnings | ⛈️ Weak | EPS vs analyst expectations |
| Cash & Debt | ⛅ Moderate | Balance sheet strength |
| Price | $128.29 | Market Cap | — |
| Exchange | NASDAQ Global Select | | |
Plain-English Analysis
What's it worth?
Based on 5-year performance trends, Insmed Incorporated has historically delivered strong returns. Sign up free for full valuation analysis including P/E, DCF estimates, and Stockbruh's plain-English take on whether this stock looks cheap or expensive right now.
How the business works
Insmed Incorporated, a kickass biopharmaceutical company, develops life-changing therapies for peeps with rare diseases. With headquarters in Bridgewater, New Jersey, they've got ARIKAYCE for treating lung disease and Brensocatib for bronchiectasis, plus more cool stuff coming. Sign up free for competitor and revenue breakdown ↗
Are they building the future?
Growth has been challenging recently. Revenue or earnings are showing weak trends. Sign up free to see the full picture including forward projections.
What's ahead?
Recent earnings have disappointed — missing expectations or reporting losses. Sign up free to see the full earnings analysis and what's driving the weakness.